SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 5 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38 | -49.3% | 140 | +4.5% | 0.00% | – |
| Q1 2023 | $75 | -23.5% | 134 | +1.5% | 0.00% | – |
| Q4 2022 | $98 | – | 132 | +3.1% | 0.00% | – |
| Q3 2022 | $0 | – | 128 | +3.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 124 | -99.4% | 0.00% | – |
| Q1 2022 | $103,000 | -63.1% | 21,402 | -31.5% | 0.00% | – |
| Q4 2021 | $279,000 | -63.9% | 31,253 | -41.6% | 0.00% | – |
| Q3 2021 | $772,000 | +1413.7% | 53,491 | +1425.7% | 0.00% | – |
| Q2 2021 | $51,000 | -8.9% | 3,506 | -15.2% | 0.00% | – |
| Q1 2021 | $56,000 | -16.4% | 4,135 | +78.4% | 0.00% | – |
| Q4 2020 | $67,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |